FOR IMMEDIATE RELEASE
February 8, 2021
NCODA Welcomes Five New Executive Council Members
Cazenovia, NY – NCODA, Inc. is pleased to announce the addition of five new members to the Executive Council. Paul Chadwick (Florida Cancer Specialists & Research Institute), Lucio Gordan, MD (Florida Cancer Specialists & Research Institute), Benjamin Lowentritt, MD (Chesapeake Urology), Stacey McCullough, PharmD (Tennessee Oncology | Park Pharmacy), and Michelle Taymuree, PharmD, MBA (Sutter Health) joined the Council in February 2021.
Paul Chadwick serves as the Chief Procurement Officer at Florida Cancer Specialists & Research Institute in Fort Myers, Fl. Paul is responsible for oversight of in-clinic IV drugs and the medically integrated oral pharmacy. Lucio Gordan, MD serves as the President & Managing Physician of Florida Cancer Specialists & Research Institute, and practices at the FCS Gainesville Cancer Center. As a cancer researcher and the recipient of research grants, Dr. Gordan is actively engaged in clinical studies. Benjamin Lowentritt, MD serves as Director of Minimally Invasive Surgery and Robotics and Director of the Prostate Cancer Care Program at Chesapeake Urology. Stacey McCullough, PharmD serves as the Senior Vice President of Pharmacy for Tennessee Oncology, one of the nation’s most prestigious community-based oncology practices. She works with executive and clinical leadership in synchronizing business acuity to clinical excellence and developing strategies for system implementation across multiple clinical sites. Michelle Taymuree, PharmD, MBA serves as the Oncology Manager of Pharmacy Services (system-wide) at Sutter Health. Michelle is responsible for managing Clinical Pathways, authoring guidelines and policies, and developing pharmacy initiatives.
“Over the last month we have added five highly skilled and well respected cancer care professionals to our Executive Council,” said NCODA President Jim Schwartz, RPh. “These new Council members are well positioned to help us continue executing on our Mission in 2021.” The new Executive Council members will be integral to NCODA’s continued growth and success in the years to come. NCODA Founder and Executive Director Michael Reff, RPh, MBA noted – “As NCODA grows, it is important that the organization has leaders with unique backgrounds and experiences so that we can continue to shape the cancer care landscape…and do it in a way that is Patient-Centered and Always Collaborative!”
NCODA, Inc. is a 501(c)(3) organization. Our Mission is to empower the medically-integrated oncology team to deliver positive, patient-centered outcomes by providing leadership, expertise, quality standards and best practices. For more information about NCODA’s Executive Council and general updates, visit www.ncoda.org.